ASX - By Stock
|
SZL |
Re:
Sezzle - Journey to $1 Billion
|
|
tandax
|
258 |
71K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
258
|
71K
|
2
|
|
ASX - By Stock
|
AMS |
Re:
Ann: Response to AFR Article
|
|
tandax
|
59 |
27K |
3 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
59
|
27K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Change of Director's Interest Notice
|
|
tandax
|
40 |
8.5K |
3 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
40
|
8.5K
|
3
|
|
ASX - By Stock
|
AMS |
Re:
Ann: Response to AFR Article
|
|
tandax
|
59 |
27K |
10 |
02/09/22 |
02/09/22 |
ASX - By Stock
|
59
|
27K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust and WEHI to Investigate HTLV-1 Viral Infections
|
|
tandax
|
42 |
11K |
13 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
42
|
11K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
HC PAA SH Volume
|
|
tandax
|
180 |
40K |
6 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
180
|
40K
|
6
|
|
ASX - By Stock
|
HYD |
Re:
Ann: First AngelMed Guardian implants in Asia-Pacific
|
|
tandax
|
399 |
165K |
5 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
399
|
165K
|
5
|
|
Charts
|
PAA Biotech |
Re:
PHARMAUST ALL SET FOR ELY LILLY T/O
|
|
tandax
|
272 |
81K |
15 |
13/08/20 |
13/08/20 |
Charts
|
272
|
81K
|
15
|
|
Charts
|
PAA Biotech |
Re:
PHARMAUST ALL SET FOR ELY LILLY T/O
|
|
tandax
|
272 |
81K |
17 |
11/08/20 |
11/08/20 |
Charts
|
272
|
81K
|
17
|
|
Charts
|
PAA Biotech |
Re:
PHARMAUST ALL SET FOR ELY LILLY T/O
|
|
tandax
|
272 |
81K |
9 |
11/08/20 |
11/08/20 |
Charts
|
272
|
81K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Organoid Clinical Trial against CoVID-19
|
|
tandax
|
163 |
50K |
32 |
09/08/20 |
09/08/20 |
ASX - By Stock
|
163
|
50K
|
32
|
|
ASX - By Stock
|
HT8 |
Re:
Ann: Trading Halt
|
|
tandax
|
43 |
15K |
6 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
43
|
15K
|
6
|
|
ASX - By Stock
|
HT8 |
Re:
HT8 - Turnaround Story
|
|
tandax
|
98 |
25K |
8 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
98
|
25K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Organoid Clinical Trial against CoVID-19
|
|
tandax
|
163 |
50K |
30 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
163
|
50K
|
30
|
|
Charts
|
PAA |
Re:
(PAA) TURNING HEADS.
|
|
tandax
|
54 |
15K |
14 |
05/08/20 |
05/08/20 |
Charts
|
54
|
15K
|
14
|
|
Charts
|
PAA |
Re:
(PAA) TURNING HEADS.
|
|
tandax
|
54 |
15K |
27 |
05/08/20 |
05/08/20 |
Charts
|
54
|
15K
|
27
|
|
ASX - By Stock
|
HT8 |
Re:
HT8 - Turnaround Story
|
|
tandax
|
98 |
25K |
5 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
98
|
25K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 2A & s708 notice (exercise of staff options)
|
|
tandax
|
20 |
4.4K |
18 |
02/08/20 |
02/08/20 |
ASX - By Stock
|
20
|
4.4K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PharmAust clinical trials show monepantel fights covid 19
|
|
tandax
|
29 |
10K |
18 |
02/08/20 |
02/08/20 |
ASX - By Stock
|
29
|
10K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
tandax
|
181 |
39K |
15 |
02/08/20 |
02/08/20 |
ASX - By Stock
|
181
|
39K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 2A & s708 notice (exercise of staff options)
|
|
tandax
|
20 |
4.4K |
30 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
20
|
4.4K
|
30
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 2A & s708 notice (exercise of options)
|
|
tandax
|
16 |
5.0K |
23 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
16
|
5.0K
|
23
|
|
ASX - By Stock
|
HT8 |
Re:
HT8 - Turnaround Story
|
|
tandax
|
98 |
25K |
7 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
98
|
25K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Report delivered under Option Agreement
|
|
tandax
|
461 |
92K |
44 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
461
|
92K
|
44
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1503 End of Phase 2 Milestone with FDA
|
|
tandax
|
186 |
52K |
5 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
186
|
52K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1503 End of Phase 2 Milestone with FDA
|
|
tandax
|
186 |
52K |
10 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
186
|
52K
|
10
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1503 End of Phase 2 Milestone with FDA
|
|
tandax
|
186 |
52K |
6 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
186
|
52K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Report delivered under Option Agreement
|
|
tandax
|
461 |
92K |
53 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
461
|
92K
|
53
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 2A & s708 notice (exercise of options)
|
|
tandax
|
42 |
10K |
26 |
12/07/20 |
12/07/20 |
ASX - By Stock
|
42
|
10K
|
26
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 2A & s708 notice (exercise of options)
|
|
tandax
|
42 |
10K |
11 |
11/07/20 |
11/07/20 |
ASX - By Stock
|
42
|
10K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 2A & s708 notice (exercise of options)
|
|
tandax
|
39 |
9.3K |
7 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
39
|
9.3K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 2A & s708 notice (exercise of options)
|
|
tandax
|
39 |
9.3K |
16 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
39
|
9.3K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 2A & s708 notice (exercise of options)
|
|
tandax
|
39 |
9.3K |
18 |
07/07/20 |
07/07/20 |
ASX - By Stock
|
39
|
9.3K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 2A & s708 notice (exercise of options)
|
|
tandax
|
39 |
9.3K |
8 |
07/07/20 |
07/07/20 |
ASX - By Stock
|
39
|
9.3K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 2A & s708 notice (exercise of options)
|
|
tandax
|
39 |
9.3K |
8 |
07/07/20 |
07/07/20 |
ASX - By Stock
|
39
|
9.3K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
JULY Pharmaust Dual Catalysts
|
|
tandax
|
220 |
49K |
13 |
07/07/20 |
07/07/20 |
ASX - By Stock
|
220
|
49K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
JULY Pharmaust Dual Catalysts
|
|
tandax
|
220 |
49K |
10 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
220
|
49K
|
10
|
|
ASX - By Stock
|
PAA Medicine |
Re:
Clinical Trials
|
|
tandax
|
309 |
76K |
19 |
03/07/20 |
03/07/20 |
ASX - By Stock
|
309
|
76K
|
19
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Successful $4.5 million Placement & Launch of SPP
|
|
tandax
|
140 |
36K |
7 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
140
|
36K
|
7
|
|
ASX - By Stock
|
4DS |
Re:
Ann: 4DS Update-Progress at imec
|
|
tandax
|
170 |
53K |
6 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
170
|
53K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Shareholder Update
|
|
tandax
|
196 |
43K |
8 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
196
|
43K
|
8
|
|
ASX - By Stock
|
4DS |
Re:
Ann: 4DS Update-Progress at imec
|
|
tandax
|
170 |
53K |
10 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
170
|
53K
|
10
|
|
ASX - By Stock
|
4DS |
Re:
Ann: 4DS Update-Progress at imec
|
|
tandax
|
170 |
53K |
2 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
170
|
53K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Shareholder Update
|
|
tandax
|
196 |
43K |
13 |
24/06/20 |
24/06/20 |
ASX - By Stock
|
196
|
43K
|
13
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Trading Halt
|
|
tandax
|
79 |
24K |
13 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
79
|
24K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Confirmation of Preliminary COVID-19 Results
|
|
tandax
|
380 |
86K |
11 |
22/06/20 |
22/06/20 |
ASX - By Stock
|
380
|
86K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Confirmation of Preliminary COVID-19 Results
|
|
tandax
|
380 |
86K |
13 |
22/06/20 |
22/06/20 |
ASX - By Stock
|
380
|
86K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Confirmation of Preliminary COVID-19 Results
|
|
tandax
|
380 |
86K |
8 |
22/06/20 |
22/06/20 |
ASX - By Stock
|
380
|
86K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Confirmation of Preliminary COVID-19 Results
|
|
tandax
|
380 |
86K |
6 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
380
|
86K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Voluntary Suspension
|
|
tandax
|
356 |
83K |
15 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
356
|
83K
|
15
|
|